Octopus mothers slam themselves against rocks and eat their own arms before their eggs hatch. Scientists have discovered what ...

After dropping a fifth straight game after his team's 2-0 start, New Orleans Saints head coach Dennis Allen discusses the ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

This is an audio transcript of the FT News Briefing podcast episode: ‘Israel accused of implementing ‘starvation plan’ in Gaza’ [MUSIC PLAYING] Sonja Hutson Good morning f ...

Eight years ago, in what now seems like an act of reckless naivety, I bought my brother a 23andMe at-home DNA-test birthday present. Now the struggling company may sell its treasure trove of genetic ...

The troubled startup has records of millions of Americans' DNA and personal information.

A data breach and full board resignation have left 23andMe's future unclear. Here's what we know and how users can delete ...

For the last decade, 23andMe has been known worldwide for offering genetic testing, ancestry tracing and health information ...

After a large data breach in 2023, the value of 23andMe has plummeted, prompting concerns that the company -- and all its users' genetic data -- could soon be up for sale.

在充满挑战的市场环境中，23andMe Holding Co. (ME)的股价已触及52周新低，跌至0.27美元。这家基因检测和个性化医疗保健公司在过去一年面临重大阻力，股价表现反映了这一点，一年来惊人地下跌了68.73%。投资者对公司的增长前景和盈利能力表示担忧，导致股价呈现下跌趋势。这个新低对公司来说是一个关键点，因为它正寻求重新赢得股东的信心，并可能在快速发展的生物技术行业中重振其业务战略。

Following a data, 23andMe is currently facing an uncertain future, with many customers fearing the genetic information may be ...